Arteris, Inc.·4

Apr 7, 4:28 PM ET

Kunkel Joachim 4

4 · Arteris, Inc. · Filed Apr 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Arteris (AIP) Director Joachim Kunkel Receives 899-Share Award

What Happened
Director Joachim Kunkel was granted 899 fully vested restricted shares of Arteris, Inc. on April 5, 2026. The Form 4 reports an acquisition price of $0.00 (award/compensation). The company valued the grant using an average trading price of $15.98 (Feb 20–Apr 2, 2026), implying a notional value of approximately $14,366 for the award. The reporting person elected to defer receipt of the shares.

Key Details

  • Transaction date: April 5, 2026; filing date: April 7, 2026 (appears timely under the Form 4 window).
  • Transaction type/code: Award/Grant (A); price reported: $0.00 per share.
  • Shares granted: 899; implied value at $15.98/share: ~$14,366.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes: F1 — fully vested restricted stock representing retainer fees elected in shares instead of cash; F1 notes valuation used ($15.98 average). F2 — the reporting person elected to defer receipt of the shares.

Context
This was a compensation retainer converted into stock (fully vested restricted shares), not an open-market purchase or sale. Such awards reflect routine director compensation and, because they were elected in lieu of cash and deferred, do not by themselves indicate insider buying or selling sentiment.

Insider Transaction Report

Form 4
Period: 2026-04-05
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-04-05+89969,627 total
Footnotes (2)
  • [F1]Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on April 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from February 20, 2026 through April 2, 2026, which was $15.98.
  • [F2]The Reporting Person elected to defer the receipt of shares.
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim|2026-04-07

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT